Clinical Trials for Carrick Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Carrick Therapeutics

Clinical Trials (3)

NCT06600789
A Modular Phase 1/2 Study with CT7439 in Participants with Solid Malignancies
PHASE1/PHASE2Recruiting
50 participants
Started: Aug 16, 2024 · Completed: May 22, 2026
1 condition1 sponsor6 locations
NCT06125522
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)
PHASE1/PHASE2Active, not recruiting
11 participants
Started: Jan 10, 2024 · Completed: Nov 4, 2025
1 condition3 sponsors21 locations
NCT05963997
A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer
PHASE1/PHASE2Active, not recruiting
49 participants
Started: Oct 9, 2023 · Completed: Dec 23, 2025
3 conditions2 sponsors23 locations